These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 55523)
1. A randomized pilot study comparing two regimens in the treatment of squamous cell carcinoma. Moseley HS; Sasaki T; McConnell DB; Merhoff GC; Wilson WL; Grage TB; Wiess AJ; Fletcher WS J Surg Oncol; 1976; 8(1):35-42. PubMed ID: 55523 [TBL] [Abstract][Full Text] [Related]
2. Trial of 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU; NSC-79037) in advanced bronchogenic carcinoma 1,2,3. Stolinsky DC; Bull FE; Pajak TF; Bateman JR Oncology; 1975; 31(5-6):288-92. PubMed ID: 174040 [TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy with CCNU (NSC-79037),hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in advanced bronchogenic carcinoma. DiBella NJ; Nelson RA; Norgard MJ Oncology; 1975; 32(2):82-5. PubMed ID: 815858 [TBL] [Abstract][Full Text] [Related]
4. CCNU and bleomycin in the treatment of cancer: a Southwest Oncology Group Study. Hoogstraten B; Haas CD; Haut A; Talley RW; Rivkin S; Isaacs BL Med Pediatr Oncol; 1975; 1(2):95-106. PubMed ID: 59307 [TBL] [Abstract][Full Text] [Related]
5. A combination of adriamycin, CCNU and hydroxyurea in the treatment of disseminated bronchogenic carcinoma. Alberto P; Barrelet L; Chapuis B; Garcia B Eur J Cancer (1965); 1975 Nov; 11(11):795-9. PubMed ID: 767111 [No Abstract] [Full Text] [Related]
6. [Treatment of epidermoid head and neck cancer with cisplatinum/bleomycin vs methotrexate/vindesine]. Schröder M; von Heyden HW; Beyer JH; Klee M Laryngol Rhinol Otol (Stuttg); 1981 Jun; 60(6):331-3. PubMed ID: 6167831 [TBL] [Abstract][Full Text] [Related]
11. Phase-II study of cis-diammine-dichloro platinum (cis-platinum), bleomycin and methotrexate for advanced squamous cell carcinoma of head and neck. Espana P; Smith F; Abrams J; Haidak D; Ueno W; Woolley P; Schein P Cancer Chemother Pharmacol; 1984; 12(2):98-100. PubMed ID: 6199132 [TBL] [Abstract][Full Text] [Related]
12. Vinblastine, methotrexate, bleomycin, in the management of head and neck cancer. Vanhaelen C; Bertrand M; De Jager R; Kenis Y Eur J Cancer (1965); 1979 Nov; 15(11):1315-8. PubMed ID: 93540 [No Abstract] [Full Text] [Related]
13. Bleomycin (NSC-125066) and CCNU (NSC-79037) in the combination chemotherapy of mopp-resistant hodgkin's disease. Kurnick JE; White M; Ware DE; Robinson WA Cancer Chemother Rep; 1975; 59(6):1147-50. PubMed ID: 56989 [TBL] [Abstract][Full Text] [Related]
14. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck. Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121 [TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinoma. McMahon LJ; Jones SE; Durie BG; Salmon SE Cancer Lett; 1975 Nov; 1(2):97-102. PubMed ID: 65213 [TBL] [Abstract][Full Text] [Related]
16. Combined chemotherapy of head and neck squamous cell carcinomas with methotrexate, bleomycin, and hydroxyurea. Medenica R; Alberto P; Lehmann W Cancer Chemother Pharmacol; 1981; 5(3):145-9. PubMed ID: 6170472 [TBL] [Abstract][Full Text] [Related]
17. Chemotherapy for head and neck cancer. Comparison of cisplatin + vinblastine + bleomycin versus methotrexate. Williams SD; Velez-Garcia E; Essessee I; Ratkin G; Birch R; Einhorn LH Cancer; 1986 Jan; 57(1):18-23. PubMed ID: 2416423 [TBL] [Abstract][Full Text] [Related]
18. Methotrexate, vinblastine, epidoxorubicin, and bleomycin as second-line chemotherapy for recurrent and/or metastatic squamous cell carcinoma of the head and neck. Gebbia V; Valenza R; Testa A; Borsellino N; Cannata G; Restivo S; Speciale R; Ingria F; Spadafora G; Gebbia N ORL J Otorhinolaryngol Relat Spec; 1994; 56(5):279-82. PubMed ID: 7526312 [TBL] [Abstract][Full Text] [Related]